The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)—A Protocol for an International Cohort Study
Authors:
- Anne-Rose W. SchutASAnne-Rose W. Schut
- Milea J. M. TimbergenMTMilea J. M. Timbergen
- Emma LidingtonELEmma Lidington
- Dirk J. GrünhagenDGDirk J. Grünhagen
- Winette T. A. van der GraafWinette T. A. van der Graaf
- Stefan SleijferSSStefan Sleijfer
- Winan J. van HoudtWHWinan J. van Houdt
- Johannes J. BonenkampJBJohannes J. Bonenkamp
- Eugenie YoungerEugenie Younger
- Alison DunlopADAlison Dunlop
- Robin L. JonesRobin L. Jones
- Cornelis VerhoefCornelis Verhoef
Open Access
Abstract
Sporadic desmoid-type fibromatosis (DTF) is a rare soft tissue tumour with an unpredictable clinical course. These tumours are incapable of metastasising, but their local aggressive tumour growth and tendency to recur locally can result in a substantial symptom burden. Measuring the impact of DTF on health-related quality of life (HRQoL) can be challenging due to the variable clinical presentation of the disease. Therefore, a HRQoL instrument assessing DTF-specific issues is needed. The QUALIFIED study aims to (1) pre-test a previously developed DTF-specific HRQoL tool (the DTF-QoL); (2) evaluate prevalence of HRQoL issues in adult DTF patients; and (3) identify subgroups at risk of impaired HRQoL. This study (NCT04289077) is an international, multicentre, cross-sectional, observational cohort study. Patients ≥ 18 years with sporadic DTF from the Netherlands and the United Kingdom will be invited to complete a set of questionnaires specifically composed for this patient group. Questionnaires will be completed using PROFILES (Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship). Analyses will include testing the psychometric properties of the DTF-QoL and evaluating the prevalence of HRQoL issues using the DTF-QoL, EORTC QOL-C30 and EQ-5D-5L, among other questionnaires. This study will provide insight into HRQoL issues experienced by patients with DTF. Awareness of these issues and the implementation of the DTF-QoL in research and clinical practice can help to improve overall HRQoL and to provide personalised care.Keywords
Funding Information
- Stichting Coolsingel (566)
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research (B038)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI198.007)
- Social Psychology Fellowship from the Dutch Cancer Society (KUN2015-7527)
This publication has 33 references indexed in Scilit:
- Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patientsEuropean Journal of Cancer, 2015
- Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously ThoughtAnnals of Surgical Oncology, 2013
- A Prognostic Nomogram for Prediction of Recurrence in Desmoid FibromatosisAnnals of Surgery, 2013
- Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)Annals of Oncology, 2013
- Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosisBritish Journal of Surgery, 2013
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Optimal recall periods for patient-reported outcomes: challenges and potential solutionsCurrent Medical Research and Opinion, 2009
- Validation of a Decisional Conflict ScaleMedical Decision Making, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Convergent and discriminant validation by the multitrait-multimethod matrix.Psychological Bulletin, 1959